Stocks
Alnylam Pharmaceuticals, Inc.ALNY
NASDAQHealthcareBiotechnology$313.41-1.20%
A biotechnology company focused on developing RNA interference (RNAi) therapeutics that silence disease-causing genes. Its approved drugs target rare genetic conditions, including hereditary transthyretin-mediated amyloidosis, while a broader pipeline spans cardiometabolic, hepatic, and neurologic d...
Market Cap: $41.6B52W Range: $205.87 – $495.55
Congressional Interest in Alnylam Pharmaceuticals, Inc. (ALNY)
9 members of Congress have disclosed 31 trades in Alnylam Pharmaceuticals, Inc. (ALNY), a Healthcare company. The buy/sell breakdown shows 16 purchases versus 15 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
31
Unique Politicians
9
Buys
16
Sells
15
Who in Congress Is Trading ALNY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-05-12 | Jefferson Shreve | sell | $15K – $50K |
| 2024-11-19 | MICHAEL T. MCCAUL | sell | $50K – $100K |